IRIDEX Corporation (IRIX)
USD 0.88
(-7.25%)
USD 0.88
(-7.25%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -4.28 Million USD | 64.72% |
| 2022 | -12.15 Million USD | 42.66% |
| 2021 | -21.19 Million USD | -184.97% |
| 2020 | -7.43 Million USD | 21.24% |
| 2019 | -9.44 Million USD | 55.44% |
| 2018 | -21.19 Million USD | 2.36% |
| 2017 | -21.7 Million USD | 8.59% |
| 2016 | -23.74 Million USD | -137.59% |
| 2015 | -9.99 Million USD | 24.87% |
| 2014 | -13.3 Million USD | 1.05% |
| 2013 | -13.44 Million USD | -12.97% |
| 2012 | -11.9 Million USD | -10.31% |
| 2011 | -10.78 Million USD | -19.69% |
| 2010 | -9.01 Million USD | -53.88% |
| 2009 | -5.85 Million USD | -945.31% |
| 2008 | 693 Thousand USD | -82.97% |
| 2007 | 4.07 Million USD | 119.33% |
| 2006 | -21.05 Million USD | -66.35% |
| 2005 | -12.65 Million USD | -21.91% |
| 2004 | -10.38 Million USD | 1.52% |
| 2003 | -10.54 Million USD | -14.75% |
| 2002 | -9.18 Million USD | -99.13% |
| 2001 | -4.61 Million USD | 53.86% |
| 2000 | -9.99 Million USD | -3.66% |
| 1999 | -9.64 Million USD | -66.29% |
| 1998 | -5.8 Million USD | 41.41% |
| 1997 | -9.9 Million USD | -98.4% |
| 1996 | -4.99 Million USD | -315.83% |
| 1995 | -1.2 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -2.89 Million USD | 32.42% |
| 2024 Q2 | -1.82 Million USD | 37.13% |
| 2023 Q4 | -4.28 Million USD | 38.62% |
| 2023 Q2 | -8.56 Million USD | 10.16% |
| 2023 Q1 | -9.53 Million USD | 21.58% |
| 2023 Q3 | -6.98 Million USD | 18.41% |
| 2023 FY | -4.28 Million USD | 64.72% |
| 2022 FY | -12.15 Million USD | 42.66% |
| 2022 Q1 | -18.2 Million USD | 14.12% |
| 2022 Q2 | -15.75 Million USD | 13.48% |
| 2022 Q3 | -13.88 Million USD | 11.85% |
| 2022 Q4 | -12.15 Million USD | 12.46% |
| 2021 Q1 | -24.05 Million USD | -223.42% |
| 2021 Q4 | -21.19 Million USD | 6.53% |
| 2021 FY | -21.19 Million USD | -184.97% |
| 2021 Q3 | -22.67 Million USD | 2.55% |
| 2021 Q2 | -23.26 Million USD | 3.27% |
| 2020 Q3 | -7.43 Million USD | -12.37% |
| 2020 FY | -7.43 Million USD | 21.24% |
| 2020 Q1 | -8.27 Million USD | 12.4% |
| 2020 Q2 | -6.61 Million USD | 20.05% |
| 2020 Q4 | -7.43 Million USD | -0.08% |
| 2019 Q2 | -11.75 Million USD | 9.4% |
| 2019 FY | -9.44 Million USD | 55.44% |
| 2019 Q4 | -9.44 Million USD | -0.37% |
| 2019 Q3 | -9.4 Million USD | 19.95% |
| 2019 Q1 | -12.97 Million USD | 38.79% |
| 2018 Q3 | -23.72 Million USD | -47.87% |
| 2018 Q4 | -21.19 Million USD | 10.67% |
| 2018 Q2 | -16.04 Million USD | 13.37% |
| 2018 FY | -21.19 Million USD | 2.36% |
| 2018 Q1 | -18.52 Million USD | 14.67% |
| 2017 Q1 | -23.85 Million USD | -0.47% |
| 2017 Q3 | -22.75 Million USD | 7.49% |
| 2017 Q4 | -21.7 Million USD | 4.59% |
| 2017 FY | -21.7 Million USD | 8.59% |
| 2017 Q2 | -24.59 Million USD | -3.08% |
| 2016 Q3 | -9.57 Million USD | 16.87% |
| 2016 Q2 | -11.52 Million USD | -9.58% |
| 2016 Q1 | -10.51 Million USD | -5.19% |
| 2016 FY | -23.74 Million USD | -137.59% |
| 2016 Q4 | -23.74 Million USD | -147.96% |
| 2015 Q4 | -9.99 Million USD | 2.13% |
| 2015 Q2 | -12.2 Million USD | 7.0% |
| 2015 Q3 | -10.21 Million USD | 16.31% |
| 2015 FY | -9.99 Million USD | 24.87% |
| 2015 Q1 | -13.12 Million USD | 1.36% |
| 2014 Q1 | -13.96 Million USD | -3.91% |
| 2014 Q2 | -12.86 Million USD | 7.92% |
| 2014 FY | -13.3 Million USD | 1.05% |
| 2014 Q3 | -13.04 Million USD | -1.4% |
| 2014 Q4 | -13.3 Million USD | -2.0% |
| 2013 Q3 | -14.08 Million USD | -4.32% |
| 2013 Q1 | -11.58 Million USD | 2.69% |
| 2013 Q2 | -13.5 Million USD | -16.61% |
| 2013 FY | -13.44 Million USD | -12.97% |
| 2013 Q4 | -13.44 Million USD | 4.58% |
| 2012 FY | -11.9 Million USD | -10.31% |
| 2012 Q4 | -11.9 Million USD | 13.35% |
| 2012 Q3 | -13.73 Million USD | 0.37% |
| 2012 Q2 | -13.78 Million USD | 0.51% |
| 2012 Q1 | -13.85 Million USD | -28.43% |
| 2011 FY | -10.78 Million USD | -19.69% |
| 2011 Q1 | -8.56 Million USD | 4.94% |
| 2011 Q4 | -10.78 Million USD | -13.15% |
| 2011 Q3 | -9.53 Million USD | -7.44% |
| 2011 Q2 | -8.87 Million USD | -3.57% |
| 2010 Q4 | -9.01 Million USD | -27.1% |
| 2010 Q2 | -7 Million USD | -9.98% |
| 2010 Q1 | -6.36 Million USD | -8.65% |
| 2010 Q3 | -7.09 Million USD | -1.31% |
| 2010 FY | -9.01 Million USD | -53.88% |
| 2009 Q4 | -5.85 Million USD | -33.62% |
| 2009 Q2 | -2.14 Million USD | -1056.76% |
| 2009 FY | -5.85 Million USD | -945.31% |
| 2009 Q1 | -185 Thousand USD | -126.7% |
| 2009 Q3 | -4.38 Million USD | -104.86% |
| 2008 Q4 | 693 Thousand USD | -77.1% |
| 2008 Q2 | 1.9 Million USD | 50.47% |
| 2008 FY | 693 Thousand USD | -82.97% |
| 2008 Q1 | 1.26 Million USD | -68.85% |
| 2008 Q3 | 3.02 Million USD | 58.6% |
| 2007 Q3 | 4.62 Million USD | -20.52% |
| 2007 Q4 | 4.07 Million USD | -12.02% |
| 2007 FY | 4.07 Million USD | 119.33% |
| 2007 Q1 | 1.56 Million USD | 107.45% |
| 2007 Q2 | 5.82 Million USD | 270.94% |
| 2006 Q4 | -21.05 Million USD | -374.23% |
| 2006 FY | -21.05 Million USD | -66.35% |
| 2006 Q1 | -3.25 Million USD | 74.27% |
| 2006 Q2 | -3.73 Million USD | -14.8% |
| 2006 Q3 | -4.43 Million USD | -18.75% |
| 2005 FY | -12.65 Million USD | -21.91% |
| 2005 Q3 | -11.05 Million USD | -5.47% |
| 2005 Q4 | -12.65 Million USD | -14.47% |
| 2005 Q1 | -6.2 Million USD | 40.26% |
| 2005 Q2 | -10.48 Million USD | -69.01% |
| 2004 Q3 | -8.61 Million USD | -11.21% |
| 2004 Q4 | -10.38 Million USD | -20.54% |
| 2004 Q2 | -7.74 Million USD | 18.29% |
| 2004 Q1 | -9.47 Million USD | 10.09% |
| 2004 FY | -10.38 Million USD | 1.52% |
| 2003 Q3 | -7.8 Million USD | 3.95% |
| 2003 Q4 | -10.54 Million USD | -35.14% |
| 2003 Q2 | -8.12 Million USD | 31.69% |
| 2003 FY | -10.54 Million USD | -14.75% |
| 2003 Q1 | -11.88 Million USD | -29.41% |
| 2002 FY | -9.18 Million USD | -99.13% |
| 2002 Q1 | -5.85 Million USD | -26.95% |
| 2002 Q2 | -6.35 Million USD | -8.45% |
| 2002 Q3 | -7.37 Million USD | -16.12% |
| 2002 Q4 | -9.18 Million USD | -24.56% |
| 2001 Q2 | -7.75 Million USD | -2.76% |
| 2001 Q3 | -5.72 Million USD | 26.21% |
| 2001 Q4 | -4.61 Million USD | 19.4% |
| 2001 FY | -4.61 Million USD | 53.86% |
| 2001 Q1 | -7.54 Million USD | 24.5% |
| 2000 Q4 | -9.99 Million USD | 6.12% |
| 2000 Q1 | -10.93 Million USD | -13.37% |
| 2000 Q2 | -11.69 Million USD | -6.94% |
| 2000 Q3 | -10.65 Million USD | 8.93% |
| 2000 FY | -9.99 Million USD | -3.66% |
| 1999 Q1 | -7.8 Million USD | -34.48% |
| 1999 FY | -9.64 Million USD | -66.29% |
| 1999 Q2 | -8.7 Million USD | -11.54% |
| 1999 Q3 | -10.2 Million USD | -17.24% |
| 1999 Q4 | -9.64 Million USD | 5.44% |
| 1998 Q3 | -2.5 Million USD | 56.9% |
| 1998 FY | -5.8 Million USD | 41.41% |
| 1998 Q1 | -10.2 Million USD | -3.03% |
| 1998 Q2 | -5.8 Million USD | 43.14% |
| 1998 Q4 | -5.8 Million USD | -132.0% |
| 1997 FY | -9.9 Million USD | -98.4% |
| 1997 Q1 | -4.29 Million USD | 14.03% |
| 1997 Q2 | -9.99 Million USD | -132.87% |
| 1997 Q3 | -9.39 Million USD | 6.01% |
| 1997 Q4 | -9.9 Million USD | -5.43% |
| 1996 Q3 | -14.49 Million USD | 5.91% |
| 1996 Q4 | -4.99 Million USD | 65.56% |
| 1996 FY | -4.99 Million USD | -315.83% |
| 1996 Q2 | -15.4 Million USD | 0.0% |
| 1995 Q4 | -1.2 Million USD | 0.0% |
| 1995 FY | -1.2 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 115.833% |
| BrainsWay Ltd. | -10.32 Million USD | 58.45% |
| Cerus Corporation | 84.35 Million USD | 105.083% |
| Envoy Medical, Inc. | -3.81 Million USD | -12.428% |
| electroCore, Inc. | -9.95 Million USD | 56.926% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 16.332% |
| IceCure Medical Ltd | -9.93 Million USD | 56.835% |
| Inogen, Inc. | -103.56 Million USD | 95.86% |
| OrthoPediatrics Corp. | -9.26 Million USD | 53.728% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -17.77% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 67.26% |
| MaxCyte, Inc. | -27.76 Million USD | 84.555% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 16.545% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -644.746% |
| Orthofix Medical Inc. | 96.44 Million USD | 104.446% |
| PAVmed Inc | 29.08 Million USD | 114.742% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 74.686% |
| RxSight, Inc. | -6.68 Million USD | 35.808% |
| Sight Sciences, Inc. | -102.71 Million USD | 95.825% |
| SI-BONE, Inc. | 5.72 Million USD | 174.952% |
| TELA Bio, Inc. | -3.94 Million USD | -8.584% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 107.481% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 1318.182% |
| Acutus Medical, Inc. | 12.27 Million USD | 134.921% |
| Talis Biomedical Corporation | -57.06 Million USD | 92.486% |
| Spectral AI, Inc. | -3.5 Million USD | -22.479% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 91.072% |
| CVRx, Inc. | -59.95 Million USD | 92.848% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 316.113% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 435.62% |
| Bioventus Inc. | 372.51 Million USD | 101.151% |
| Venus Concept Inc. | 74.3 Million USD | 105.771% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 57.886% |
| LivaNova PLC | 62.53 Million USD | 106.857% |
| 908 Devices Inc. | -115.09 Million USD | 96.274% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 101.337% |
| Nemaura Medical Inc. | 9.92 Million USD | 143.204% |
| NeuroPace, Inc. | 54.33 Million USD | 107.891% |
| LENSAR, Inc. | -18.31 Million USD | 76.584% |
| Apyx Medical Corporation | -5.15 Million USD | 16.754% |
| Cutera, Inc. | 288.3 Million USD | 101.487% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 157.059% |
| BioSig Technologies, Inc. | 262 Thousand USD | 1736.641% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 90.217% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 53.386% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.305% |
| Axonics, Inc. | -77.19 Million USD | 94.445% |
| Outset Medical, Inc. | 67.67 Million USD | 106.336% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 97.591% |
| IRadimed Corporation | -47.71 Million USD | 91.014% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -41.705% |
| INVO Bioscience, Inc. | 8.45 Million USD | 150.739% |
| Telesis Bio, Inc. | 32.63 Million USD | 113.139% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -71.374% |
| Varex Imaging Corporation | 316.9 Million USD | 101.353% |
| Quipt Home Medical Corp. | 81.73 Million USD | 105.246% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -54.134% |
| Pulmonx Corporation | -42.36 Million USD | 89.877% |
| Dynatronics Corporation | 6.2 Million USD | 169.116% |
| Modular Medical, Inc. | -8.04 Million USD | 46.68% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 0.209% |
| Semler Scientific, Inc. | -57.13 Million USD | 92.494% |
| InMode Ltd. | -135.39 Million USD | 96.833% |
| Bruker Corporation | 891.3 Million USD | 100.481% |
| Cytosorbents Corporation | 4.18 Million USD | 202.534% |
| DexCom, Inc. | 2.02 Billion USD | 100.211% |
| Align Technology, Inc. | -840.47 Million USD | 99.49% |
| Viveve Medical, Inc. | -13.81 Million USD | 68.957% |
| ZimVie Inc. | 450.41 Million USD | 100.952% |
| Movano Inc. | -5.86 Million USD | 26.901% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 96.811% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -644.746% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 316.113% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 101.202% |
| Profound Medical Corp. | -18.17 Million USD | 76.412% |
| Insulet Corporation | 798.1 Million USD | 100.537% |
| enVVeno Medical Corporation | -2.21 Million USD | -93.327% |
| Surmodics, Inc. | -12.01 Million USD | 64.308% |
| iCAD, Inc. | -21.2 Million USD | 79.782% |
| Nuwellis, Inc. | -2.81 Million USD | -52.111% |
| Biotricity, Inc. | 23.09 Million USD | 118.569% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 104.579% |
| Aethlon Medical, Inc. | -4.5 Million USD | 4.746% |
| InspireMD, Inc. | -8.04 Million USD | 46.7% |
| PAVmed Inc. | 29.08 Million USD | 114.742% |
| BIOLASE, Inc. | 11.34 Million USD | 137.8% |
| Beyond Air, Inc. | 6.22 Million USD | 168.839% |
| FONAR Corporation | -14.66 Million USD | 70.761% |
| AxoGen, Inc. | 32.26 Million USD | 113.29% |
| Vivani Medical, Inc. | 42 Thousand USD | 10309.524% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 59.767% |
| Inari Medical, Inc. | -7.16 Million USD | 40.12% |
| UFP Technologies, Inc. | 40.77 Million USD | 110.517% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 239.737% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 10.13% |
| Tenon Medical, Inc. | -1.25 Million USD | -241.673% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 43.623% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 64.046% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.193% |
| Sintx Technologies, Inc. | 905 Thousand USD | 573.812% |
| NanoVibronix, Inc. | -3.27 Million USD | -30.811% |
| Quanterix Corporation | -132.95 Million USD | 96.775% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -54.134% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 80.827% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.569% |
| TransMedics Group, Inc. | 121.13 Million USD | 103.54% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 83.621% |
| NeuroMetrix, Inc. | -1.49 Million USD | -187.579% |
| Hyperfine, Inc. | -75.61 Million USD | 94.329% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 102.818% |
| Biomerica, Inc. | -3.38 Million USD | -26.677% |
| Bone Biologics Corporation | -3.02 Million USD | -41.679% |
| AVITA Medical, Inc. | -26.23 Million USD | 83.653% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -133.245% |
| Silk Road Medical, Inc | 64.42 Million USD | 106.656% |